Prof. Dürdane Serap KURUCA


Istanbul Medical Faculty, Basic Medical Sciences

Department of Physiology


WoS Research Areas: Clinical Medicine (Med), Natural Sciences (Sci), Life Sciences (Life), Clinical Medicine, Natural Sciences General, Immunology, Pharmacology & Toxicology, Hematology, Oncology, Multidisciplinary Sciences, Immunology, Toxicology


Avesis Research Areas: Medicine, Health Sciences, Fundamental Medical Sciences, Human Physiology, Microbiology and Clinical Microbiology, Immunology, Internal Medicine Sciences, Child Health and Diseases, Pediatric Hematology, Pharmacology and Therapeutics, Professional Sciences, Pharmaceutical Toxicology, Pharmaceutics Technology, Pharmaceutical Biotechnology


Names in Publications: kuruca se , kuruca s , Erdem-Kuruca Serap, erdem-kuruca s , KURUCA DURDANE S , KURUCA DURDANE Serap , kuruca erdem s, kuruca ds , Kuruca S.E., KURUCA S ERDEM, Kuruca Serap Erdem

Former Researcher

Email: sekuruca@istanbul.edu.tr
Office Phone: +90 212 534 0000
Web: http://aves.istanbul.edu.tr/759/
Office: 5
Address: İstanbul Tıp Fak. Millet cad. PK 34093 Çapa Şehremini/İstanbul

Metrics

Publication

215

Publication (WoS)

105

Publication (Scopus)

89

Citation (WoS)

877

H-Index (WoS)

16

Citation (Scopus)

1171

H-Index (Scopus)

20

Citation (Scholar)

11

H-Index (Scholar)

1

Citation (Sobiad)

4

H-Index (Sobiad)

1

Citation (Sum Other)

1

Project

50

Intellectual Property

2

Thesis Advisory

14

Open Access

12
UN Sustainable Development Goals

Education

1982 - 1986

1982 - 1986

Doctorate

Istanbul University, Istanbul Medical Faculty, Fizyoloji, Turkey

1975 - 1980

1975 - 1980

Undergraduate

Istanbul University, Faculty of Science, Biyoloji, Turkey

Dissertations

1986

1986

Doctorate

Kemik iliğinde lenfopoeze etkili faktörler

Istanbul University, Istanbul Medical Faculty, Fizyoloji

Foreign Languages

B2 Upper Intermediate

B2 Upper Intermediate

English

Research Areas

Medicine

Health Sciences

Fundamental Medical Sciences

Human Physiology

Microbiology and Clinical Microbiology

Immunology

Internal Medicine Sciences

Child Health and Diseases

Pediatric Hematology

Pharmacology and Therapeutics

Professional Sciences

Pharmaceutical Toxicology

Pharmaceutics Technology

Pharmaceutical Biotechnology

Academic Positions

1996 - Present

1996 - Present

Professor

Istanbul University, Istanbul Medical Faculty, Basic Medical Sciences

1991 - 1996

1991 - 1996

Associate Professor

Istanbul University, Istanbul Medical Faculty, Basic Medical Sciences

Courses

Doctorate

Doctorate

İLERİ HÜCRE FİZYOLOJİSİ

Postgraduate

Postgraduate

LABORATUAR ROTASYONU

FİZYOLOJİDE GÜNCEL KONULAR

Undergraduate

Undergraduate

Fizyoloji

Supervised Theses

Articles

All (107)
SCI-E, SSCI, AHCI (85)
SCI-E, SSCI, AHCI, ESCI (90)
ESCI (5)
Scopus (87)
TRDizin (11)
Other Publications (12)

Papers Presented at Peer-Reviewed Scientific Conferences

2023

2023

1. MEME KANSERİ KÖK HÜCRELERİNİN BİYOKİMYASAL VE MORFOLOJİK YÖNTEMLER İLE TANIMLANMASI

OKŞAK N., Korkut I. N., EROL A., DANIŞMAN KALINDEMİRTAŞ F., ÖZERKAN D., SÜLEYMANOĞLU M., et al.

SOCRATES 8th INTERNATIONAL HEALTH, ENGINEERING AND APPLIED SCIENCES CONGRESS, 28 September 2023, (Summary Text) Sustainable Development

2022

2022

3. Evaluation of the effect of mesenchymalstem cells on cytokine levels in cell culture

Erol A., Abatay Sel F., Süleymanoğlu M., Demirayak G., Kuruca D. S., Oğuz F.

HLA dergisi, 35th EFI Conference, Amsterdam, Netherlands, 17 May 2022, vol.99, pp.537, (Summary Text)

2022

2022

5. Mezenkimal Kök Hücrelerin Periferal Kan Mononükleer Hücrelere olan Etkisinin Sitokin Düzeyinde Araştırılması

Erol A., Abatay Sel F., Süleymanoğlu M., Demirayak G., Kuruca D. S., Oğuz F.

Ulusal Transplantasyon İmmünolojisi ve Genetiği Derneği, Antalya, Turkey, 14 - 17 April 2022, pp.34, (Summary Text)

2021

2021

6. Effects of Doxorubicin on In Vitro Breast Cancer Model with Lymphocyte and Monocyte Cells

ÖZEN EROĞLU G., EROL A., YAYLIM İ., KURUCA D. S.

VIII. International Congress of Molecular Medicine, 9 - 12 November 2021, (Full Text) Sustainable Development

2021

2021

7. Anti-Leukemic Effect of Wharton Jelly Derived Mesenchymal Stem Cells in Vitro

Süleymanoğlu M., Erol A., Abatay Sel F., Özdemir İ. A., Oğuz F., Kuruca D. S., et al.

VIII. International Congress of Molecular Medicine, 9 - 12 November 2021, pp.1, (Summary Text) Creative Commons License Sustainable Development

2021

2021

8. Mesenchymal Stem Cell Derived Therapy Approach For The Colorectal Cancer

Abatay Sel F., Süleymanoğlu M., Erol A., Çınar Ç., Demirayak G., Kuruca D. S., et al.

Hacettepe Acta Medica- XVII. Congress of Medical Biology and Genetics, 28 - 31 October 2021, vol.52, pp.349-351, (Summary Text) Creative Commons License

2021

2021

10. The Apoptotic Effect of Human Umbilical Cord Blood Derived Mesenchymal Stem Cells on Colorectal Cancer Cell Lines.

Abatay Sel F., Süleymanoğlu M., Erol A., Çınar Ç., Demirayak G., Kuruca D. S., et al.

VIII. International Congress of Molecular Medicine, İstanbul, Turkey, 9 - 12 November 2021, pp.1-3, (Summary Text) Creative Commons License Sustainable Development

2018

2018

12. Cytotoxic effect of vanadium complexes that has elastase enzyme inhibitor activity on breast cancer cells.

DANIŞMAN KALINDEMİRTAŞ F., KURUCA D. S., KAYA B., YANARDAĞ R., ERTİK O., ÜLKÜSEVEN B.

1st International Symposium on Graduate Research in Science Focus on Entrepreneurship and Innovation (ISGRS 2018), İstanbul, Turkey, 4 - 06 October 2018, pp.159, (Full Text) Sustainable Development

2018

2018

13. The relationship between endogen antioxidants and total oxidant and antioxidant capacity in patients with beta-thalassemia

Karakas Z., Yilmaz Y., Celik D., Annayev A., Kuruca S.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text) identifier

2018

2018

14. Examination of the Biocompatibility of Electrospun Pla/Sa/Ha Composite Nanofibers for the Bone Tissue Engineering Applications

Erdemir G., Gündüz O., Cesur S., Kuruoğlu F., Erol A., Kuruca D. S.

International Congress on Engineering and Life Science, Kastamonu, Turkey, 26 - 29 April 2018, pp.787, (Summary Text)

2018

2018

15. Biocompatibility Evalution of Coaxial Electrospun PLA/BHA/GO Composite Nanofibers

Erdemir G., Gündüz O., Ege Z. R., Özen S., Kuruoğlu F., Erol A., et al.

International Congress on Engineering and Life Science, Kastamonu, Turkey, 26 - 29 April 2018, pp.788, (Summary Text)

2017

2017

20. EFFECTIVE NEW IRON COMPLEXES ON K562 AND HL-60 CELL LINES

KAYA B., Süleymanoğlu M., KURUCA D. S., ÜLKÜSEVEN B.

5th International Bau Drug Design Congress, İstanbul, Turkey, 19 - 21 October 2017, pp.32, (Full Text)

2017

2017

24. Cytotoxic effects of Eremurus spectabilis Bieb. extracts on cancer cell lines

BAYRAK B. B., SÜLEYMANOĞLU M., ERDEM KURUCA S., YANARDAĞ R.

I. International Congress on Medicinal and Aromatic Plants “Natural and Healthy Life” TABKON’17, Konya, Turkey, 10 May - 12 June 2017, pp.562, (Full Text) Sustainable Development

2017

2017

25. Nickel(II) Complexes Based On Tetradentate Thiosemicarbazone: Synthesis, Structural Analysis And Cytotoxic Efficiency On Leukemia Cells

Süleymanoğlu M., KURUCA D. S., KAYA B., ÜLKÜSEVEN B.

IVEK 3rd International Convention Pharmaticeuticals and Pharmacies, İstanbul, Turkey, 26 - 29 April 2017, pp.309, (Full Text)

2017

2017

27. Antitumor Effects of New Iron(III) and Nickel(II) Chelates of S-methyl-thiosemicarbazones on Gastrointestinal Cell Lines

KURUCA D. S., ÜLKÜSEVEN B., ARSLAN M., BAL DEMİRCİ T., AKGÜN DAR K.

IVEK 3rd International Convention of Pharmaceuticals and Pharmasies, 26-29 Nisan 2017, Istanbul, TURKEY, İstanbul, Turkey, 26 - 29 April 2017, pp.353, (Full Text)

2017

2017

28. Iron(III) Complexes As Potential Anticancer Agents: Synthesis, Characterisation And Cytotoxic Activity

KAYA B., ÖZEN G., Süleymanoğlu M., KURUCA D. S., ÜLKÜSEVEN B.

IVEK 3rd International Convention Pharmaticeuticals and Pharmacies, İstanbul, Turkey, 26 - 29 April 2017, pp.311, (Full Text)

2015

2015

33. Total Oxidant and Antioxidant Capacity in Patients with Transfusion Dependent and Nondependent Beta Thalassemia

Karakas Z., Yilmaz Y., Celik D. D., Annayev A., Demirel S., Kuruca S. E.

57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126, (Summary Text) identifier

2015

2015

34. Cytotoxic effects of Aloe vera leaf extracts on leukemia and lymphoma cell lines.

Çandöken E., Kuruca S., AKEV N.

XXVIII. World Congress of the World Association of Societies of Pathology andLaboratory Medicine (WASPALM 2015), Cancun, Mexico, 18 - 21 November 2015, pp.1013, (Full Text)

2015

2015

36. Cytotoxic effect of flavonoids combined with imatinib on human chronic myeloid leukemia cell lines.

Birman H., Danışman Kalındemirtaş F., Çandöken E., Kuruca D. S., Melikoğlu G.

The Joint Meeting of the Federation of European Physiological Societies and the Baltic Physiological Societies in Kaunas, Kaunas, Lithuania, 26 - 29 August 2015, vol.215, no.704, pp.34, (Summary Text)

2015

2015

37. "Cytotoxic Effects Of Aloe Vera (L.) Burm. Fil. Leaf Extracts On B16f10 Murine Melanoma And Nih3t3 Mouse Embryogenic Fibroblast Cells.",

Çandöken E., KURUCA D. S., Akev N.

38th FEBS Congress“Mechanisms in Biology, St.Petersburg, Russia, 6 - 11 July 2015, pp.280, (Summary Text)

2015

2015

38. Is Vitamin D-3 has any effect on the proliferation of colorectal cancer (HCT116) cells?

Kucukhuseyin Ö., Temocin O., Turan S., Ersez M. S., Celik D., Cevatemre B., et al.

40th Congress of the Federation-of-European-Biochemical-Societies (FEBS) - The Biochemical Basis of Life, Berlin, Germany, 4 - 09 July 2015, vol.282, pp.247-248, (Summary Text) Sustainable Development identifier

2015

2015

39. EVALUATION OF PLURIPOTENT MARKERS IN CELLS OBTAINED FROM DIFFERENT HUMAN HEMATOPOETIC SOURCES

Celik D. D., Kuruca S., Aktan M., CELEBI Z.

20th Congress of European-Hematology-Association, Vienna, Austria, 11 - 14 June 2015, vol.100, pp.702, (Summary Text) identifier

2015

2015

41. "Screening Of Cytotoxicity Of Aloe Emodin On Different Cancer Cells"

Çandöken E., KURUCA D. S., Akev N.

2nd International BAU-Drug Design Symposium, İstanbul, Turkey, 17 - 19 April 2015, pp.184, (Summary Text) Sustainable Development

2014

2014

43. Burcu Oktay, Nilhan Kayaman-Apohan, Serap Erdem-Kuruca . Fabrication of nanofiber mats from electrospinning of functionalized polymers.

OKTAY B., APOHAN N. K., KURUCA D. S.

2ND INTERNATIONAL CONFERENCE ON STRUCTURAL NANO COMPOSITES (NANOSTRUC 2014), Madrid, Spain, 20 - 21 May 2014, vol.64, no.1, pp.12011, (Full Text)

2014

2014

44. Fabrication of nanofiber mats from electrospinning of functionalized polymers

Oktay B., Kayaman-Apohan N., Erdem-Kuruca S.

2nd International Conference on Structural Nano Composites (NANOSTRUC), Madrid, Spain, 20 - 21 May 2014, vol.64, (Full Text) identifier identifier

2013

2013

45. Nikel sülfat Tip I Hipersensitiviteye Yol Açabilir mi?

GELİNCİK A., ÜNAL D., DEMİRTÜRK M., Demir A., Damla Çelik D., Bildik G., et al.

XXI. Ulusal Allerji ve Klinik İmmunoloji Kongresi, Antalya, Turkey, 2 - 06 November 2013, pp.85, (Full Text)

2013

2013

46. Cytotoxic effects of Aloe vera (L.) Burm. fil. leaf extracts on B16F10 murine melanoma and NIH3T3 mouse embryogenic fibroblast cells

Candoken E., Kuruca S. E., Akev N.

38th Congress of the Federation-of-European-Biochemical-Societies (FEBS), Saint Peter, Guernsey And Alderney, 6 - 11 July 2013, vol.280, pp.516, (Summary Text) identifier

2013

2013

47. Poly (alpha-Hydroxy Ester-Urethane) Based Electrospun Biomaterials for Tissue Engineering

Kayaman-Apohan N., ÇAKMAKÇI E., Cicek C., KAHRAMAN M. V., Arslan M., Kuruca S. E.

11th International Conference on Chemical and Process Engineering (ICheaP), Milan, Italy, 2 - 05 June 2013, vol.32, pp.1087-1092, (Full Text) Sustainable Development identifier identifier

2012

2012

48. Iron and ferritin removal from serum of beta thalassemia patients with iron overload by synthetic zeolites

Aydogan M. G., Okcu A., Kuruca S., Bahtiyar N., Karakas Z.

22nd IUBMB Congress/37th FEBS Congress, Sevilla, Spain, 4 - 09 September 2012, vol.279, pp.564-565, (Summary Text) identifier

2012

2012

49. The effects of clinoptilolite-supported feeding on the iron level of tissues and blood in rats with iron overload

AYDOGAN M. G., Kuruca S. E., Uzum G., Okcu A., Bahtiyar N.

22nd IUBMB Congress/37th FEBS Congress, Sevilla, Spain, 4 - 09 September 2012, vol.279, pp.563, (Summary Text) identifier

2012

2012

51. Apoptotic effects of new iron (III) chelates of S-methyl-thiosemicarbazones on K562 cells

Kuruca D. S., Ülküseven B., Bal Demirci T., Akgün Dar K., Arslan M., Gürel E.

XXXIV World Congres International Society of Hematology, Cancun, Mexico, 25 - 28 August 2012, pp.46, (Full Text)

2011

2011

56. The effect of estrogen on ethanol induced blood brain barrier disruption in an in vitro model

Karadenizli S., ÜZÜM G., KURUCA D. S., AKGÜN DAR K., Çetin B., KAPUCU A.

Turkish Society of Physiological Sciences and FEBS, İstanbul, Turkey, 3 - 07 September 2011, (Full Text)

2011

2011

57. Cytotoxic and apoptotic effects of new 5 trifluoromethoxy 1 H indole 2 3 dione thiosemicarbazones on lymphoma and leukemia cell lines

KURUCA D. S., KARALI N. L., AKGÜN DAR K., GÜREL GÜREVİN E., KARAKAŞ Z.

International Symposium on Drug Research&Development “From chemistry to medicine”&New horizons and job opportunities for young scientists, ANTALYA, TÜRKIYE, pp.013-013, 27 - 29 May 2011

2011

2011

58. Immunological Mechanisms Underlying Decreased NK Activity in Beta-Thalassemia Major Patients

KURUCA D. S.

12th International Conference on Thalassaemia and The Haemoglobinopathies 2011, Antalya, Turkey, 1 January - 30 December 2011, pp.1-10, (Full Text)

2011

2011

59. Natural Killer Activity and In Vitro Effects of IL2 in Patients with Beta-Thalassemia Major

KURUCA D. S.

12th International Conference on Thalassaemia and The Haemoglobinopathies 2011, Antalya, Turkey, 1 January - 30 December 2011, pp.1-10, (Full Text)

2010

2010

61. In vitro culture of endothelial and fibroblast cells on photocrosslinked electrospun acrylated cellulose acetate butyrate

Çakmakçı E., Kayaman-Apohan N., KURUCA D. S., Çetin B., Karadenizli S., AKGÜN DAR K., et al.

14th International SHR Symposium, 6th International Congrees of Pathophysiology, Montreal, Canada, 22 - 25 September 2010, pp.72, (Full Text)

2010

2010

62. Apoptotic Effects of Alpha-Tocopherol Combine Antifibrotic Agents in Primary Human Tenon’s Fibroblasts

Kuruca D. S., Engin K. N., Akgün Dar K., Karadenizli S., Çetin B., Gürel E., et al.

6th International Congress of Pathophysiology, Montreal, Canada, 22 - 25 September 2010, pp.211, (Full Text)

2010

2010

63. Apoptotic and antiproliferative effects of single and combined use of alpha tocopherol and antifibrotic agents, on human endothelium cells; a comparative evaluation.

Çetin M. B., karadenizli S., Serbes U., AKGÜN DAR K., ÖZCAN F. G., Engin K. N., et al.

3rd International Congress on Cell Membranes and Oxidative Stress: Focus on Calcium Signaling and TRP Channels, Isparta, Turkey, 22 - 27 June 2010, pp.50, (Full Text)

2010

2010

67. Decreased IFN-gamma Activity in Anxiety Disorders

KURUCA D. S.

14th Multidisciplinary International Conference on Neuroscience and Biological Psychiatry, Saint Petersburg, Russia, 1 January - 30 December 2010, pp.1, (Full Text)

2010

2010

68. 6th International Congress of Pathophysiology

KURUCA D. S.

Selective Antitumor Activities of New Iron(III) and Nickel(II) Chelates of S-Methyl-Thiosemicarbazones on Cell Lines, Quebec, Canada, 1 January - 30 December 2010, vol.1, no.1, pp.1-10, (Full Text)

2009

2009

72. PHENOTYPIC AND FUNCTIONAL STUDIES OF NATURAL KILLER (NK) CELL SUBSETS IN beta-THALASSEMIA MAJOR PATIENTS

ATASEVER B., Kuruca S. E., Karakas Z., Erman B., Ergen A., Isbir T., et al.

14th Annual Meeting of the European-Hematology-Association, Berlin, Germany, 4 - 07 June 2009, vol.94, pp.500-501, (Summary Text) identifier

2009

2009

73. NATURAL KILLER ACTIVITY AND EFFECT OF IL-2 IN PATIENTS WITH beta-THALASSEMIA MAJOR

Karakas Z., Atasever B., Kuruca S. E., Erman B., Ergen A., Isbir T., et al.

14th Annual Meeting of the European-Hematology-Association, Berlin, Germany, 4 - 07 June 2009, vol.94, pp.502, (Summary Text) identifier

2008

2008

75. Correlation Between Defective NK Activity and Low Expression of CD16, NKp44 and NKG2D in Beta Thalassemia Patients

KURUCA D. S.

Blood ASH Annual Meeting, Chapel Hill, United States Of America, 1 January - 30 December 2008, vol.A5425, no.112, pp.1, (Full Text)

2007

2007

77. Brickell Üzerinde Farmakognozik Araştırmalar

KURUCA D. S.

17. Bitkisel İlaç Hammaddeleri Toplantısı, Aydın, Turkey, 1 January - 30 December 2007, pp.1-10, (Full Text)

2007

2007

78. Cytotoxicity tests in leukema

KURUCA D. S.

2nd Congress of Molecular Medicine, İstanbul, Turkey, 1 January - 30 December 2007, pp.1, (Full Text)

2007

2007

79. Colchicum Baytopiorum C.D.Brickell Üzerinde Farmakognozik Araştırmalar

PIRILDAR S., ATASEVER B., KURUCA D. S., PAPOUSKOVA B.

17. Bitkisel İlaç Hammaddeleri Toplantısı, Aydın, Turkey, 1 January - 30 December 2007, pp.1-10, (Full Text)

2006

2006

80. Cytotoxic effects of four new thiosemicarbazones on K562 and ECV 304 cells

Bal T., Atasever B., Solakoglu Z., Erdem-Kuruca S., Ulkuseven B.

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.345-346, (Summary Text) identifier

2006

2006

81. Cytotoxic effects of different parts of Colchicum Baytopiorum on K562 and HL60 cells

KURUCA D. S.

A Young Scientists Symposium “Future Trends in Phytochemistry”, Olomuc, Czech Republic, 1 January - 30 December 2006, pp.1, (Full Text)

2006

2006

82. Cytotoxic effects of seeds of Colchicum Baytopiorum and Colchicum Bivonae on K562 cells

KURUCA D. S.

nternational Symposium “Chemistry, Pharmacology and Biosynthesis of Alkaloids, Antalya, Turkey, 1 January - 30 December 2006, vol.1, no.1, pp.1, (Full Text) Sustainable Development

2006

2006

83. In vitro drug resistance in childhood ALL and effects on prognosis.

KURUCA D. S.

ISP fifth quadrennial conference, Beijing, China, 1 January - 30 December 2006, vol.22, no.13, pp.390, (Full Text)

2005

2005

84. In vitro drug resistance in childhood ALL and effect on prognosis

KURUCA D. S.

XXX. World Congress of the International Society of Hematology, İstanbul, Turkey, 1 January - 30 December 2005, vol.1, no.1, pp.1, (Full Text)

2005

2005

85. Çocukluk çağı lösemilerinde in vitro ilaç direncinin prognostik faktörlerle ilişkisi

KURUCA D. S.

31. Ulusal Fizyoloji Kongresi, Gaziantep, Turkey, 1 January - 30 December 2005, pp.1, (Full Text)

2005

2005

86. Effect of antioxidants on oxidative stress in patients with Thalassemia Major: in vitro study

KURUCA D. S.

XXX. World Congress of the International Society of Hematology, İstanbul, Turkey, 1 January - 30 December 2005, vol.1, no.1, pp.1, (Full Text)

2005

2005

87. In vitro anthracycline resistance in childhood ALL

KURUCA D. S.

XXX. World Congress of the International Society of Hematology, 2005, İstanbul, Turkey, 1 January - 30 December 2005, vol.1, no.1, pp.1, (Full Text)

2005

2005

88. Akut lenfoblastik lösemide kromozom translokasyonlarının ilaç direncine etkileri

KURUCA D. S.

31. Ulusal Fizyoloji Kongresi, Gaziantep, Turkey, 1 January - 30 December 2005, pp.1-10, (Full Text)

2004

2004

89. Relationship between DNA index and cellular drug resistance in children with newly diagnosed acute lymphoblastic leukemia.

Karakas Z., GOKCE S., Kuruca S., DEMIREL G., Ozbek U., AKCAY A., et al.

46th Annual Meeting of the American-Society-of-Hematology, California, United States Of America, 4 - 07 December 2004, vol.104, (Summary Text) identifier

2004

2004

91. Effects of iron overload on cellular immunity in patients with beta thalassemia major

KURUCA D. S., AKYOLCU M. C., TOPLAN Ş. S., ATASEVER B., AKGÜN DAR K.

Macro and Trace Elements 22. Workshop, Jena, Germany, 24 - 25 September 2004, pp.748, (Full Text)

2004

2004

92. Effects of iron overload on cellular immunitiy in patients with beta thallasemia major.

KURUCA D. S., Atasever B., ADEMOĞLU E., KARAKAŞ Z., AKYOLCU M. C., Aydemir B., et al.

Macro and Trace Elements. Mengen-und Spurenelemente, Berlin, Germany, 24 - 27 September 2004, vol.22, pp.738-745, (Full Text)

2004

2004

93. Talasemili hastalarda NK aktivitesinin antioksidanlarla modülasyonu

KURUCA D. S.

30. Ulusal Fizyoloji Kongresi, Konya, Turkey, 1 January - 30 December 2004, vol.14, pp.71-75, (Full Text)

2004

2004

94. Yeni tanılı akut lenfoblastik lösemili çocuklarda DNA indeksi ve ilaç direnci ilişkisi

KURUCA D. S.

26. Pediatri Günleri, İstanbul, Turkey, 1 January - 30 December 2004, pp.1, (Full Text)

2004

2004

95. Çocukluk çağı akut lenfoblastik lösemilerinde in vitro ilaç direnci

KURUCA D. S.

26. Pediatri Günleri, İstanbul, Turkey, 1 January - 30 December 2004, pp.1, (Full Text)

2004

2004

96. İnce N. ?- Talasemi majörlü hastalarda hücresel immunite

KURUCA D. S.

30. Ulusal Fizyoloji Kongresi, Konya, Turkey, 1 January - 30 December 2004, vol.14, pp.71-75, (Full Text)

2003

2003

98. In vitro drug resistance in childhood ALL and its relation with the prognostic factors

Karakas Z., Kuruca S., AKCAY A., Atasever B., AYDOGAN G., BULBUL A., et al.

5th International Symposium on Leukemia and Lymphoma, Amsterdam, Netherlands, 12 - 15 March 2003, vol.17, pp.680, (Summary Text) identifier

2003

2003

99. Can in vitro drug resistance predict the outcome of childhood myelodysplastic syndromes and acute myeloblastic leukemia?

KURUCA D. S.

III. International Symposium on MDS in Childhood, Stresa, Italy, 1 January - 30 December 2003, pp.1, (Full Text)

2002

2002

100. Nerium oleander bitkisinden elde edilen ekstrelerin antilösemik etkileri

Turan N., AKGÜN DAR K., KURUCA D. S., MERİÇLİ H. F., Süzergöz F., Atasever B.

28. Ulusal Fizyoloji Kongresi, İzmir, Turkey, 24 - 27 September 2002, pp.156, (Full Text)

2002

2002

101. Lösemi hücrelerine flavonoidlerin etkisi

Atasever B., AKGÜN DAR K., KURUCA D. S., Seyhanlı V., MERİÇLİ A. H.

28. Ulusal Fizyoloji Kongresi, İzmir, Turkey, 24 - 27 September 2002, pp.155, (Full Text)

2002

2002

103. K562 eritrolösemi hücrelerinde büyüme faktörleri ile busulfanın sitotoksik etkisinin modulasyonu

AKGÜN DAR K., KURUCA D. S., Ertan N. Z.

28. Ulusal Fizyoloji Kongresi, İzmir, Turkey, 24 - 27 September 2002, pp.154, (Full Text)

2001

2001

104. Importance of drug resistance profile in children in Turkey

KARAKAŞ Z., KURUCA D. S., SÜZERGÖZ F., GÜNDÜZ G.

4th International Symposium on Drug resistance in Leukemia and lymphoma, Amsterdam, Netherlands, 01 January 2001, (Summary Text)

1998

1998

105. Prognostic value of P gp expression and related functions in childhood acute leukemia

KARAKAŞ Z., LEYLA A., KURUCA D. S., DEMİREL G., ARASLI M., SÜZERGÖZ F., et al.

3rd International Symposium on Drug resistance in Leukemia and lymphoma, Amsterdam, Netherlands, 1 - 03 January 1998, (Summary Text)

Books

1999

1999

2. Prognostic value of p-gp expression and related function in childhood acute leukemia

Kuruca D. S., Karakaş Z.

in: Advances in Experimental Medicine and BiologyDrug Resistans in Leukemia and Lymphoma, G.J.L.Kaspers,R. Pieters,A.J.P. Veerman, Editor, Springer, New York, pp.21-28, 1999

Episodes in the Encyclopedia

Funded Projects

2022 - 2025

2022 - 2025

Gözenekli Aljinat Lifi Ve Aktif Yara Örtüsü GeliştirilmesiSustainable Development

TUBITAK Project , 3501 - National Young Researcher Career Development Program

Kuruca D. S., Gürarslan A.(Executive)

2022 - 2024

2022 - 2024

Mikroakışkan Sistem ile Entegre Silisyuma Katkılı Ferromanyetik Nano-öbeklerin Kullanımı ile Dolaşan Kanser Hücrelerinin YakalanmasıSustainable Development

TÜBİTAK International Bilateral Joint Cooperation Program Project , Ministry of Innovative Development of the Republic of Uzbekistan, MID Uzbekistan Bilateral Joint Cooperation Program

Kuruca D. S., Trabzon L.(Executive)

2020 - 2023

2020 - 2023

HODGKIN LENFOMA VE NONHODGKIN LENFOMA HASTALIĞINDA MİKROBİYOTA ETKİSİ, IL17 ve IL12 İLE ETKİLEŞİM

Project Supported by Higher Education Institutions , BAP Research Project

ÖNCÜL M. O. (Executive), ERDEM F., AKTAŞ Z., OĞUZ F., KURUCA D. S., GÜNEL G., et al.

2020 - 2023

2020 - 2023

Mikrofluidik Sistemlerde Hematopoetik Kök Hücre İzolasyonu ve Karakterizasyonu

Project Supported by Higher Education Institutions , BAP PhD

KURUCA D. S. (Executive), OKŞAK N.

2020 - 2021

2020 - 2021

Yeşil Sentez Yöntemiyle Bitkilerden Yeni Nesil Nanopartikül Sentezi Antikanser ve Antibakteriyel Etkileri

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive), SAVUT CAN S.

2014 - 2017

2014 - 2017

Yeni sentez edilen S-metil tiyosemikarbazonların demir şelatlarının gastrik ve hepatoma hücre dizilerinde antikanser etkileri

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

2014 - 2016

2014 - 2016

Lösemi hücrelerinden kanser kök hücrelerinin izolasyonu ve tanımlanmasıSustainable Development

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

2013 - 2016

2013 - 2016

Poli eter-ester bazlı fumarilli PLGAFAME hidrojeller üzerinde in vitro hücre proliferasyonu

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

2013 - 2016

2013 - 2016

1,2 Dimetilhidrazin ile Oluşturulan Kolon Kanseri Modelinde Zeolit Destekli Beslenmenin Kanser Gelişimine EtkileriSustainable Development

Project Supported by Higher Education Institutions , BAP Research Project

KURUCA D. S. (Executive), AKGÜN DAR K., KAPUCU A., AVTAN L.

2012 - 2016

2012 - 2016

Aloe vera (L.) Burm. fil. bitkisi yaprak ekstresinin antitümör etkisinin hücre kültürlerinde incelenmesi

Project Supported by Higher Education Institutions , BAP Research Project

AKEV N. (Executive), ÇANDÖKEN E., KURUCA D. S.

2014 - 2014

2014 - 2014

Beta-talasemi hastalarının bağışıklık sistemi üzerine demir yükünden kaynaklanan oksidatif stresin etkileri

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

2012 - 2014

2012 - 2014

Sıçanlarda klinoptilolitle beslenmenin kronik demir toksisitesine etkileri

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

2010 - 2014

2010 - 2014

İlk defa sentez edilen S-metil-tiyosemikarbazon şelatlarının K562 lösemi hücreleri üzerindeki sitotoksik etkileri

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

2012 - 2012

2012 - 2012

The effects of clinoptilolite-supported feeding on the iron level of tissues and blood in rats with iron overload

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

2009 - 2011

2009 - 2011

Tiyosemikarbozonların ECV304 endotel hücreleri üzerine etkileri

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

2009 - 2011

2009 - 2011

Vanadiumlu tiyosemikarbozonların in vitro sitotoksik etkileri

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

2008 - 2011

2008 - 2011

Hematopoietik kök hücrelere kortikosteroidlerin apoptotik etkileri ve çeşitli sitokinlerle bu etkinin modülasyonu

Project Supported by Higher Education Institutions , BAP MSc

KURUCA D. S. (Executive)

2008 - 2011

2008 - 2011

İN VİTRO KAN BEYİN BARİYERİ MODELİNDE ETANOL İLE OLUŞTURULAN BARİYER HASARI ÜZERİNE ÖSTROJENİN ETKİSİ

Project Supported by Higher Education Institutions , BAP MSc

KURUCA D. S. (Executive)

2007 - 2011

2007 - 2011

K562 eritrolösemi hücrelerinde antikanser ilaçların interferonla modulasyonu

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

2010 - 2010

2010 - 2010

İnsan tenon fibroblastları üzerine antifibrotik ilaçlar ve alfa tokoferolün in vitro apoptotik etkileriSustainable Development

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

2010 - 2010

2010 - 2010

Kollagen modifiye polimerlerde in vitro hücre yapışması ve proliferasyonunun incelenmesi

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

2007 - 2010

2007 - 2010

Beta Talasemi majörlü hastalarda NK (Natural Killer ) aktivitesini etkileyen faktörlerin araştırılması

Project Supported by Higher Education Institutions , BAP PhD

KURUCA D. S. (Executive)

2007 - 2010

2007 - 2010

talasemi hastalarında oksidatif stress parametreleri

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

2009 - 2009

2009 - 2009

Doku mühendisliği yöntemleriyle elde edilen poliester hidrojeller üzerinde çeşitli hücrelerin in vitro proliferasyonu

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

2008 - 2008

2008 - 2008

İn vitro sitotoksite testleri ve kullanım alanları

Project Supported by Higher Education Institutions , BAP Other

KURUCA D. S. (Executive)

Peer Reviews in Scientific Publications

September 2015

September 2015

Kanser Kök Hücre Paneli

Other Journals

January 2015

January 2015

Human and Experimental Toxicology

SCI Journal

March 2014

March 2014

Human and Experimental Toxicology

SCI Journal



Scholarships

1992 - Present

1992 - Present

Post doc araştırma

Official Institutions of Foreign Countries

Citations

Total Citations (WOS): 809

h-index (WOS): 16

Jury Memberships

December-2014

December 2014

Post Graduate

- üniversite

May-2014

May 2014

Associate Professor Exam

- Selçuk üniversitesi

April-2014

April 2014

Associate Professor Exam

- Koç üniv.

May-2002

May 2002

Post Graduate

- İst.Tıp Fak.

April-2002

April 2002

Doctorate

- İstanbul Tıp Fak.

May-1997

May 1997

Associate Professor Exam

- Ankara Üniversitesi

April-1994

April 1994

Post Graduate

- İstanbul Tıp Fak.